InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by SULLIVAN LOUIS W, Director. Director active across 2 companies, notably Emergent BioSolutions Inc.. In total, 10 filings have been recorded. The latest transaction was filed on 26 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations10 total
08,446 shares0
Common Stock
SEC:0001367644-22-000089:0·
€448,9276,310 shares@ €71.14540.0019% mcap22.1% of flow
Common Stock
SEC:0001415889-22-005696:0·
01,680 shares0
Common Stock
SEC:0001127602-21-020758·
01,680 shares0
Common Stock
SEC:0001127602-21-020758:0·
05,027 shares0
Common Stock
SEC:0001367644-21-000097·
05,027 shares0
Common Stock
SEC:0001367644-21-000097:0·
€789,24615,000 shares@ €52.61640.0033% mcap100.0% of flow
Common Stock
SEC:0001127602-21-016406·
€789,24615,000 shares@ €52.61640.0033% mcap38.9% of flow
Common Stock
SEC:0001127602-21-016406:0·
€158,21310,305 shares@ €15.3530.039% mcap100.0% of flow
Common Stock
SEC:0001367644-21-000075·
€158,21310,305 shares@ €15.3530.039% mcap50.0% of flow
Common Stock
SEC:0001367644-21-000075:0·
10 of 10 declarations
About SULLIVAN LOUIS W
Louis W. Sullivan is a Board Member at Emergent BioSolutions Inc. and United Therapeutics Corp. He plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing the activities of the board. Sullivan is recognized for his commitment to innovation and social responsibility.
